What Grade Are You In? The Role of Targeted Therapy in Pediatric Diffuse High-Grade Gliomas
Join us for this live webinar in an ongoing educational series designed for pharmacists, physicians, nurses, advanced practice providers, and other members of the interprofessional oncology care team!
Register today to learn from expert pharmacy specialists about clinical considerations and management strategies for patients with cancer.
In Two Weeks! Friday, August 30, 2024
12:00 – 1:00 PM EDT (UTC -4)
Presented By:
 |
Shirley Qiong Yan, PharmD, BCOP
Memorial Sloan Kettering Cancer Center |
| |
|
Learning Objectives:
Following this activity, participants should be able to:
- Describe the general approach to treatment for pediatric high-grade gliomas (pHGG).
- Identify pertinent biomarkers and molecular alterations that impact the stratification and treatment of pHGG.
- Summarize the relevant data for targeted therapy and discuss potential agents in the pipeline in the treatment for pHGG.
Fees:
There is no fee to attend this webinar.
Accreditation:
This educational program is approved for continuing education credit for pharmacists, physicians, nurses, PAs, and other oncology professionals.
Upcoming Pharmacy Updates Webinar:
- Friday, September 27 | Kidney Cance
Supporters:
This activity is supported by educational grants from GSK and Menarini-Stemline. This educational activity is supported by a medical education grant from Exelixis, Inc. This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. |
